Get the Stockscreener App
1.92
4.00%
-0.08
After Hours:
1.89
-0.03
-1.56%
Revelation Biosciences Inc stock is traded at $1.92, with a volume of 250.86K.
It is down -4.00% in the last 24 hours and down -20.66% over the past month.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
See More
Previous Close:
$2.00
Open:
$2
24h Volume:
250.86K
Relative Volume:
0.56
Market Cap:
$3.26M
Revenue:
-
Net Income/Loss:
$-15.52M
P/E Ratio:
-0.1033
EPS:
-18.58
Net Cash Flow:
$-16.61M
1W Performance:
-33.10%
1M Performance:
-20.66%
6M Performance:
-43.53%
1Y Performance:
-86.81%
1-Day Range:
$1.90
$2.01
1-Week Range:
$1.90
$2.90
52-Week Range:
$0.702
$20.16
Revelation Biosciences Inc Stock (REVB) Company Profile
Name
Revelation Biosciences Inc
Sector
Industry
Phone
650-800-3717
Address
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
Compare REVB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
REVB
Revelation Biosciences Inc
|
1.92 | 4.20M | 0 | -15.52M | -16.61M | -18.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Revelation Biosciences Inc Stock (REVB) Latest News
Price action breakdown for Revelation Biosciences Inc. Equity WarrantFed Meeting & Safe Capital Investment Plans - Newser
Has Revelation Biosciences Inc. found a price floorJobs Report & Growth Oriented Trading Recommendations - Newser
Applying Wyckoff theory to Revelation Biosciences Inc. Equity Warrant stockJuly 2025 Drop Watch & Smart Allocation Stock Reports - Newser
Understanding Revelation Biosciences Inc.’s price movementEarnings Miss & Real-Time Volume Trigger Notifications - Newser
Sector ETF performance correlation with Revelation Biosciences Inc.2025 Historical Comparison & Weekly Setup with High ROI Potential - Newser
Can momentum traders help lift Revelation Biosciences Inc.Trade Performance Summary & Detailed Earnings Play Alerts - Newser
Revelation Biosciences Inc.’s volatility index tracking explainedTrade Volume Report & Low Risk High Win Rate Stock Picks - Newser
Will Revelation Biosciences Inc. Equity Warrant price bounce be sustainableJuly 2025 Sentiment & Verified Momentum Watchlists - Newser
What data driven models say about Revelation Biosciences Inc. Equity Warrant’s futureVolume Spike & Precise Buy Zone Identification - Newser
Is Revelation Biosciences Inc. reversing from oversold territoryPortfolio Update Summary & Advanced Swing Trade Entry Plans - Newser
Evaluating Revelation Biosciences Inc. Equity Warrant with trendline analysis2025 Top Decliners & Risk Controlled Daily Plans - Newser
Using data models to predict Revelation Biosciences Inc. stock movementJuly 2025 Opening Moves & Fast Entry and Exit Trade Plans - Newser
What candlestick patterns are forming on Revelation Biosciences Inc.July 2025 Spike Watch & Long-Term Safe Return Strategies - Newser
Is Revelation Biosciences Inc. stock ready for a breakout2025 Top Decliners & AI Driven Stock Reports - Newser
Is it time to cut losses on Revelation Biosciences Inc.Market Performance Recap & Expert Verified Movement Alerts - Newser
Published on: 2025-09-12 04:18:05 - Newser
Is Revelation Biosciences Inc. forming a bottoming baseTrade Analysis Report & Low Drawdown Investment Strategies - Newser
Leading vs lagging indicators on Revelation Biosciences Inc. performanceJuly 2025 Rallies & Daily Price Action Insights - Newser
Predicting Revelation Biosciences Inc. Equity Warrant trend using moving averages2025 Momentum Check & Technical Pattern Recognition Alerts - Newser
Visual analytics tools that track Revelation Biosciences Inc. Equity Warrant performanceDividend Hike & Daily Entry Point Trade Alerts - Newser
How hedge fund analytics apply to Revelation Biosciences Inc. stockTreasury Yields & Daily Profit Focused Screening - Newser
Price momentum metrics for Revelation Biosciences Inc. explainedJuly 2025 Volume & Fast Moving Market Watchlists - Newser
Reversal indicators forming on Revelation Biosciences Inc. Equity Warrant stockQuarterly Profit Report & Weekly Market Pulse Updates - Newser
Using AI based signals to follow Revelation Biosciences Inc. Equity WarrantJuly 2025 Price Swings & Short-Term Swing Trade Alerts - Newser
Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study - Livingston Daily
Using RSI to spot recovery in Revelation Biosciences Inc.Trade Risk Summary & Step-by-Step Swing Trade Plans - Newser
Is this a good reentry point in Revelation Biosciences Inc. Equity Warrant2025 Market Outlook & Intraday High Probability Setup Alerts - Newser
Will Revelation Biosciences Inc. benefit from macro trendsEarnings Overview Summary & Community Verified Swing Trade Signals - Newser
Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds - Sacramento Bee
$9.6 Million Cash Infusion: Revelation Biosciences Executes Strategic Warrant Deal with 5-Year Extension - Stock Titan
Using economic indicators to assess Revelation Biosciences Inc. Equity Warrant potential2025 Winners & Losers & High Accuracy Trade Alerts - Newser
Risk vs reward if holding onto Revelation Biosciences Inc. Equity WarrantStop Loss & Daily Profit Maximizing Tips - Newser
Revelation Biosciences Inc. Equity Warrant stock trend outlook and recovery pathJuly 2025 Drop Watch & Daily Profit Focused Stock Screening - Newser
Real time pattern detection on Revelation Biosciences Inc. stockJuly 2025 Chart Watch & Weekly Watchlist for Hot Stocks - Newser
What machine learning models say about Revelation Biosciences Inc.July 2025 Earnings & High Win Rate Trade Alerts - Newser
Applying chart zones and confluence areas to Revelation Biosciences Inc.Quarterly Profit Report & Daily Profit Focused Screening - Newser
Signal strength of Revelation Biosciences Inc. Equity Warrant stock in tech scannersEarnings Risk Summary & Technical Buy Zone Confirmation - Newser
Does Revelation Biosciences Inc. Equity Warrant qualify in momentum factor screening2025 Stock Rankings & Long-Term Investment Growth Plans - Newser
Risk adjusted return profile for Revelation Biosciences Inc. Equity Warrant analyzedTrade Entry Summary & Real-Time Buy Zone Alerts - Newser
How to build a dashboard for Revelation Biosciences Inc. stockWeekly Risk Report & Community Consensus Trade Signals - Newser
Revelation Biosciences Announces Special Webcast to Review Positive Top-line Clinical Data - Eagle-Tribune
Breakthrough: Single Dose of Revelation Bio's Gemini Drug Normalizes Inflammation in Chronic Kidney Disease - Stock Titan
Can you recover from losses in Revelation Biosciences Inc.Earnings Risk Report & Detailed Earnings Play Alerts - Newser
Revelation Biosciences Inc Stock (REVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):